Package 0378-3520-91

{"route": ["ORAL"], "spl_id": "88dccf91-6e62-4f5f-849d-1ffa8bf8df9d", "openfda": {"upc": ["0303783520919"], "unii": ["ID1GU2627N"], "rxcui": ["402109"], "spl_set_id": ["3a1424d8-844c-4e24-9ebd-b2c2b61b61a3"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3520-91)", "package_ndc": "0378-3520-91", "marketing_start_date": "20170918"}], "brand_name": "Fosamprenavir Calcium", "product_id": "0378-3520_88dccf91-6e62-4f5f-849d-1ffa8bf8df9d", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "P-Glycoprotein Inducers [MoA]", "Protease Inhibitor [EPC]"], "product_ndc": "0378-3520", "generic_name": "fosamprenavir calcium", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosamprenavir Calcium", "active_ingredients": [{"name": "FOSAMPRENAVIR CALCIUM", "strength": "700 mg/1"}], "application_number": "ANDA204060", "marketing_category": "ANDA", "marketing_start_date": "20170918", "listing_expiration_date": "20261231"}